A prospective multicenter observational study of cell‐mediated immunity as a predictor for cytomegalovirus infection in kidney transplant recipients-Reference-Cited by-同舟云学术

A prospective multicenter observational study of cell‐mediated immunity as a predictor for cytomegalovirus infection in kidney transplant recipients

Published:2019-03-15 Issue:9 Volume:19 Page:2505-2516
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Kumar Deepali¹,Chin‐Hong Peter²,Kayler Liise³,Wojciechowski David⁴,Limaye Ajit P.⁵,Osama Gaber A.⁶,Ball Simon⁷,Mehta Aneesh K.⁸,Cooper Matthew⁹,Blanchard Ted¹⁰,MacDougall James¹¹,Kotton Camille N.¹²

Affiliation:

1. Transplant Infectious Diseases and Multi‐Organ Transplant Program University Health Network Toronto Canada

2. Division of Infectious Diseases University of California – San Francisco San Francisco California

3. Erie County Medical Center Buffalo New York

4. Division of Nephrology Massachusetts General Hospital Boston Massachusetts

5. University of Washington Medical Center Seattle Washington

6. WCMC Houston Texas

7. UHB Birmingham UK

8. Division of Infectious Diseases Emory University School of Medicine Atlanta Georgia

9. Medstar Georgetown Transplant Institute Washington District of Columbia

10. Oxford Immunotec Marlborough Massachusetts

11. BioBridges Wellesley Massachusetts

12. Division of Infectious Diseases Massachusetts General Hospital Boston Massachusetts

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.15315

Reference18 articles.

1. Transplant Infectious Diseases: A Review of the Scientific Registry of Transplant Recipients Published Data

2. Cytomegalovirus Seroprevalence in the United States: The National Health and Nutrition Examination Surveys, 1988–2004

3. CMV: Prevention, Diagnosis and Therapy

4. The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation

5. The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update;Transplantation Reviews;2024-12

2. Cell-mediated Immunity to Guide Primary Prophylaxis for CMV Infection in Organ Transplant Recipients: A Multicenter Single-arm Prospective Study;Transplantation;2024-08-20

3. Immune Control of Human Cytomegalovirus (HCMV) Infection in HCMV-Seropositive Solid Organ Transplant Recipients: The Predictive Role of Different Immunological Assays;Cells;2024-08-08

4. Pathogen-specific cell-mediated immunity to guide the management of cytomegalovirus in solid organ transplantation: state of the art clinical review;Expert Review of Clinical Immunology;2024-07-24

5. SARS-CoV-2 superinfection in CD14+ monocytes with latent human cytomegalovirus (HCMV) promotes inflammatory cascade;Virus Research;2024-07